PPARA and coronary artery disorder: The pathway analysis of CHD-associated proteins suggests that the interplay of galectin-4 and the predicted activated status of both p38 MAPk signaling and interleukin-1B, representatives of inflammation pathways [36], takes place via the peroxisome proliferator activated receptor alpha (PPARA).